Reprocell Inc. (4978)

Overview

ReproCELL Incorporated is a pioneering company based in Yokohama, Japan, that specializes in providing comprehensive services and products for stem cell research and drug discovery. Founded in 2003, ReproCELL has become a crucial resource for the scientific community, leveraging its expertise to assist in the advancement of stem cell technologies and its applications in medicine. The company's focus spans from offering an array of reagents and labware for stem cell research to delivering specialized services in genomics, precision medicine, and more. Through its commitment to innovation and excellence, ReproCELL aims to facilitate groundbreaking discoveries in the biomedical field.

Products and Services

Stem Cell Reagents: ReproCELL offers an extensive portfolio of stem cell reagents necessary for the cultivation and manipulation of stem cells. This includes RNA reprogramming kits, small molecules for stem cell differentiation, growth factors, cytokines, antibodies, staining kits, cell substrates, cryopreservation media, dissociation solutions, and transfection reagents. These products are designed to enhance the efficiency and reliability of stem cell experiments.

Induced Pluripotent Stem Cell (iPSC) Solutions: The company provides differentiated induced pluripotent stem cells (iPSCs) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons. These solutions empower researchers to generate and utilize iPSCs for disease modeling, drug discovery, and possibly therapeutic applications.

3D Cell Culture: Recognizing the importance of 3D cell culture systems in mimicking in vivo environments, ReproCELL offers products that facilitate the culture of cells in three dimensions. This enables more physiologically relevant cell models for research and drug discovery efforts.

Genomics Services: ReproCELL provides comprehensive genomics services, including sequencing and analysis, to support researchers in uncovering genetic underpinnings of diseases and identifying potential therapeutic targets.

Clinical Stem Cell Research: The company extends its expertise to the clinical research domain, offering services to advance the use of stem cells in therapeutic applications. This includes support for both preclinical studies and clinical trials.

Preclinical and Drug Discovery CRO: As a contract research organization (CRO), ReproCELL offers a range of services designed to accelerate preclinical drug discovery and development processes. This encompasses both in vitro and in vivo studies to evaluate the therapeutic potential of compounds.

Precision Medicine: Embracing the era of personalized medicine, ReproCELL provides precision medicine services that utilize patient-derived models and genetic information to tailor treatments to individual patients.

Human Tissue Samples: To support biomedical research, ReproCELL supplies human tissue samples, enabling researchers to study diseases and evaluate drug effects in human tissues directly.

Clinical Laboratory Services: The company offers various clinical laboratory services, including diagnostic testing and biomarker analysis, to support healthcare providers and research endeavors.

Diagnostic Services: ReproCELL's diagnostic services are designed to assist in the early detection, diagnosis, and monitoring of diseases, utilizing state-of-the-art technologies and methodologies.

Gene Editing Services: Leveraging CRISPR and other gene editing technologies, ReproCELL provides services for the precise modification of genetic material, opening up new avenues for research, disease modeling, and potential therapeutic interventions.